2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
6
Pancreatic Neoplasms
4
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thymus Neoplasms
1
Thymoma
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Sarcoma
1
Rectal Neoplasms
1
Pancreatitis
1
Pancreatic Diseases
1
Neoplasms, Germ Cell and Embryonal
1
Mesothelioma
1
Medulloblastoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Epilepsy
1
Ependymoma
1
Interventions
Temozolomide
26
Magnetic Resonance Spectroscopy
19
Etoposide
14
Cyclophosphamide
13
Radiotherapy
11
Filgrastim
10
Bevacizumab
10
Carboplatin
9
Biopsy
8
Cisplatin
7
X-Rays
6
Thiotepa
6
Specimen Handling
6
Phantoms, Imaging
6
Carmustine
6
Radiation
5
Nuclear Medicine Department, Hospital
5
Nivolumab
5
Irinotecan
5
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
5
sargramostim
4
Vincristine
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
Erlotinib Hydrochloride
4
Azacitidine
4
olaparib
3
etoposide phosphate
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ependymoma
×
Histocompatibility Testing
×
Clear all
NCT06323408
2025-03-25
BZKF-AYA
University Hospital Regensburg
Not yet recruiting
72 enrolled